12-Jun-2026
TipRanks (Thu, 11-Jun 7:53 AM ET)
Top Insiders Make Bold Moves at Ardent Health Partners
TipRanks (Mon, 8-Jun 10:13 PM ET)
TipRanks (Mon, 8-Jun 7:00 AM ET)
Ardent Health Draws Investor Attention Ahead of Key Goldman Sachs Healthcare Conference
Market Chameleon (Thu, 4-Jun 7:09 AM ET)
Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Business Wire (Wed, 3-Jun 4:15 PM ET)
Ardent Health Appoints Dave Caspers as CEO
Business Wire (Tue, 2-Jun 4:15 PM ET)
Business Wire (Thu, 14-May 8:00 AM ET)
Ardent Health Reports First Quarter 2026 Results
Business Wire (Tue, 5-May 4:15 PM ET)
Ardent Health to Participate in the Bank of America 2026 Healthcare Conference
Business Wire (Fri, 1-May 8:00 AM ET)
Kuehn Law Encourages Investors of Ardent Health, Inc. to Contact Law Firm
Globe Newswire (Thu, 23-Apr 5:05 PM ET)
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
Ardent Health trades on the NYSE stock market under the symbol ARDT.
As of June 12, 2026, ARDT stock price declined to $9.35 with 476,468 million shares trading.
ARDT has a beta of 1.12, meaning it tends to be more sensitive to market movements. ARDT has a correlation of 0.04 to the broad based SPY ETF.
ARDT has a market cap of $1.34 billion. This is considered a Small Cap stock.
Last quarter Ardent Health reported $2 billion in Revenue and $.28 earnings per share. This beat revenue expectation by $25 million and exceeded earnings estimates by $.10.
The top ETF exchange traded funds that ARDT belongs to (by Net Assets): VTI, BSVO, IWM, FYX, VXF.
ARDT has underperformed the market in the last year with a return of -31.0%, while the SPY ETF gained +24.1%. In the last 3 month period, ARDT fell short of the market, returning +1.2%, while SPY returned +11.6%. However, in the most recent 2 weeks ARDT has outperformed the stock market by returning +1.3%, while SPY returned -1.9%.
ARDT support price is $9.33 and resistance is $10.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARDT shares will trade within this expected range on the day.